Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T, Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M.
Sunakawa Y, et al. Among authors: fujii m.
Oncologist. 2024 Apr 6:oyae056. doi: 10.1093/oncolo/oyae056. Online ahead of print.
Oncologist. 2024.
PMID: 38581687
Free article.